Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.78+0.01 (+0.36%)
Close on Nov 17, 2026Market cap $23.19MP/E –Yield –
Evaxion A/S total assets
Total assets on the balance sheet at the end of each period.
Evaxion A/S's total assets was $19.38M at Jun 30, 2026. For fiscal 2025 it was $28.41M, up 127.5% from the year before. The highest annual figure on record is $40.16M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.41M | +127.5% |
| FY2024 | Dec 31, 2024 | $12.49M | -3.1% |
| FY2023 | Dec 31, 2023 | $12.89M | -41.5% |
| FY2022 | Dec 31, 2022 | $22.03M | -45.2% |
| FY2021 | Dec 31, 2021 | $40.16M | +235.7% |
| FY2020 | Dec 31, 2020 | $11.97M | +7.9% |
| FY2019 | Dec 31, 2019 | $11.08M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $19.38M | +27.2% |
| Q4 FY2025 | Dec 31, 2025 | $28.41M | +120.4% |
| Q2 FY2025 | Jun 30, 2025 | $22.45M | +34.0% |
| Q4 FY2024 | Dec 31, 2024 | $12.49M | -43.3% |
| Q2 FY2024 | Jun 30, 2024 | $15.23M | -55.2% |
| Q4 FY2023 | Dec 31, 2023 | $12.89M | -68.6% |
| Q2 FY2023 | Jun 30, 2023 | $16.75M | -58.3% |
| Q4 FY2022 | Dec 31, 2022 | $22.03M | -8.7% |
| Q2 FY2022 | Jun 30, 2022 | $34.00M | +22.9% |
| Q1 FY2022 | Mar 31, 2022 | $41.08M | +17.6% |
| Q4 FY2021 | Dec 31, 2021 | $40.16M | +235.7% |
| Q3 FY2021 | Sep 30, 2021 | $24.12M | +117.6% |
| Q2 FY2021 | Jun 30, 2021 | $27.66M | – |
| Q1 FY2021 | Mar 31, 2021 | $34.92M | – |
| Q4 FY2020 | Dec 31, 2020 | $11.97M | – |
| Q4 FY2019 | Dec 31, 2019 | $11.08M | – |
See a number that looks wrong?